Occupational Therapists in Castleton, NY Accepting Medicare
6 Occupational Therapists found. Showing 1 - 6
 Ms. Stephanie Martinelli, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2500 Pond Vw, Suite 102a, Castleton, NY 12033 Phone: 518-477-6072 Fax: 518-477-6074 |
Michelle Nash, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1477 S Schodack Rd, Castleton, NY 12033 Phone: 518-477-7103 |
 Ashby Adaptive Occupational Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 31 Seaman Ave, Castleton, NY 12033 Phone: 518-441-7958 |
 Mr. Jacob Christopher Ashby, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 31 Seaman Ave, Castleton, NY 12033 Phone: 518-441-7958 |
Erin Rigsbee, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1477 S Schodack Rd, Castleton, NY 12033 Phone: 518-477-7103 Fax: 518-477-7167 |
Mrs. Jaclyn Cara Dusenbery, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2452 Kraft Rd, Castleton, NY 12033 Phone: 518-506-9885 Fax: 518-479-0208 |
News Archive
Danube Pharmaceuticals starts trial of DNB-001 in patients with ocular hypertension
Danube Pharmaceuticals, Inc. has announced the initiation of a multi-center, randomized, double-blind, placebo controlled Phase II study with DNB-001 in 60 patients with ocular hypertension (elevated intraocular pressure).
Toward a transformative therapy for sickle cell patients
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
Simple mobility test helps predict hospital readmission in elderly heart attack patients
Close to 20% of elderly adults who have suffered a heart attack will be readmitted to the hospital within 30 days. Performance on a simple mobility test is the best predictor of whether an elderly heart attack patient will be readmitted, a Yale-led study reports.
Quantel Medical wins FDA approval for innovative Easyret photocoagulator
Quantel Medical today announced that it has received approval from the U.S. Food and Drug Administration on July 25, 2017 for the innovative new Easyret fully integrated 577nm yellow photocoagulator, which is used to treat certain forms of macular edema and peripheral retinal pathologies.
The role of growth factor in vertebrae formation
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
› Verified 8 days ago
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Chiropractors
Podiatrists
Audiologists